newsfilter
← Latest News
PR Newswire·

Börje Ekholm is proposed as new Chair of the Sobi Board of Directors

  • The Nomination Committee of Swedish Orphan Biovitrum AB (Sobi) proposes Börje Ekholm as the new Board member & Chair of the Board at the 2027 Annual General Meeting.
  • Current Chair David Meek has decided not to stand for re-election but will continue serving until May 2027.
  • Meek's tenure since December 2024 saw strong growth, new medicine launches, indication extensions, & a strengthened clinical pipeline.
  • Börje Ekholm brings over 30 years of experience in technology, investment management, & international business leadership.
  • Ekholm recently stepped down as CEO of Ericsson, has prior CEO roles at Patricia Industries & Investor AB, & currently chairs Trimble Inc.
  • Ekholm was appointed to the Nasdaq Board effective November 1, 2026, & previously served on the boards of Alibaba, Husqvarna, Nasdaq, Scania, & WM Data.
  • He was involved in creating Sobi during his tenure as CEO of Investor AB through the merger of Biovitrum & Swedish Orphan International.
  • The Nomination Committee expressed gratitude to Meek for his leadership while highlighting Ekholm's global experience & familiarity with the company.
  • Sobi is a global biopharma company with approximately 2,000 employees, reporting SEK 28 billion in revenue for 2025.
  • The full proposal details will be published before the 2027 AGM, with this announcement released on October 29, 2026.